news & events
portfolio news
20.12.12
TiGenix Completes Private Placement Raising EUR 6.7 million
19.12.12
TiGenix reports positive interim safety results of its Phase IIa study of Cx611
19.12.12
TiGenix to Raise Capital via a Private Placement of New Ordinary Shares
06.12.12
Endosense appoints Nicolas Marsault as new CFO
27.11.12
Endosense secures USD 40.3M/CHF 37.4M Series C financing
23.11.12
TiGenix focus on advanced cell therapy programs
21.11.12
Inbiomotion creates a world class Scientific Advisory Board chaired by Prof. Rob E. Coleman
13.11.12
TiGenix signs agreement for commercialization of ChondroCelect in the Middle East
08.11.12
Jon Askaa joins Inbiomotion Board of Directors – Management team strengthened
08.11.12
TiGenix Business Update & Financial Highlights for Q3 of 2012
